BD Life Sciences protozoan panel, receives FDA clearance
by Staff from Outbreak News Today on (#NH7Q)
BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company) announced Thursday the availability of the U.S. Food and Drug Administration (FDA) cleared BD MAXa Enteric Parasite Panel for use on the BD MAX System. The BD MAX Enteric Parasite Panel is the latest panel in the BD MAX Enteric ["]
